Clinical Trials in Waterloo, United States
Locations / Waterloo, United States
Delta Trials records 8 clinical trials conducted in Waterloo, United States, making it a notable site of clinical research activity. These trials across 30 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Waterloo has changed over time.
8
Total Trials
30
Conditions
1
Terminated since 2020
Browse by condition (30 total)
- Small lymphocytic lymphoma 2 trialsAll Small lymphocytic lymphoma trials
- Chronic lymphocytic leukemia 2 trialsAll Chronic lymphocytic leukemia trials
- Multiple myeloma 1 trialAll Multiple myeloma trials
- Multicentric breast carcinoma 1 trialAll Multicentric breast carcinoma trials
- All Ann arbor stage ii diffuse large b-cell lymphoma trials
- All High grade b-cell lymphoma, not otherwise specified trials
- Hormone receptor positive 1 trialAll Hormone receptor positive trials
- Breast ductal carcinoma in situ 1 trialAll Breast ductal carcinoma in situ trials
- All Ann arbor stage iii diffuse large b-cell lymphoma trials
- All Neoplastic cells with double expression of myc and bcl2 proteins present trials
- All High grade b-cell lymphoma with myc and bcl2 or bcl6 rearrangements trials
- Invasive breast carcinoma 1 trialAll Invasive breast carcinoma trials
- All Stage iib breast cancer ajcc v6 and v7 trials
- All Stage ii chronic lymphocytic leukemia trials
- Stage ib breast cancer ajcc v7 1 trialAll Stage ib breast cancer ajcc v7 trials
- All Transformed indolent b-cell non-hodgkin lymphoma to diffuse large b-cell lymphoma trials
- All Stage iv chronic lymphocytic leukemia trials
- All Stage i chronic lymphocytic leukemia trials
- Diffuse large B-cell lymphoma 1 trialAll Diffuse large B-cell lymphoma trials
- Multifocal breast carcinoma 1 trialAll Multifocal breast carcinoma trials